From WI-based FluGen Raises $3.4M For Universal Flu Vaccine Phase I Trial:

Vaccine

Vaccine—

Vaccine photo courtesy of istockphoto.com.

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Xcelerating Life Sciences Philadelphia: Special Report
Becoming the Cell & Gene Therapy Hub

Sponsored · Whitepaper
Biotech & Early Engagement Considerations: What Companies Must Consider When Developing an Asset
Evaluating an asset for development, including the vision, development and continuum capabilities, and global versus local development
PRA Health Sciences

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!